23 million Ukrainians
are at a high risk of mental disorders due to war shootings, forced relocation and the loss of loved ones.
3.5 million
are likely to be diagnosed with PTSD, a mental health disorder that some people develop after experiencing or witnessing a life-threatening event. Symptoms may include flashbacks, nightmares, severe anxiety and uncontrollable thoughts about the event.
Only
30%
of these patients are expected to recover after conventional therapy courses completely.
Psychedelic-Assisted Therapy is a method of combining the effects of psychotherapy and psychedelic compounds. Such a method is proven to have a significant therapeutic superiority compared to existing treatments of PTSD and depression.
2019
US Food and Drug Administration (FDA) has granted the breakthrough therapy designation for psilocybin for the treatment of Major Depressive Disorder
Psilocybin
2017
MDMA
US Food and Drug Administration (FDA) has granted the breakthrough therapy designation for MDMA for the treatment of PTSD
Breakthrough therapy designation
He lost a friend in the war. He lost his fingers, foot, spleen and sense of life. The PTSD diagnosis, antidepressants — panic attacks have not disappeared. The reason for living was lost.
But psychedelic therapy worked.
"My life has changed in one session."
Stanislav Gibadulin,
call sign Hitman.
Served in the Armed Forces from the beginning of the war in Donbas.
UPRA is a non-profit organization advancing the clinical use of psychedelics in PTSD patients who have exhausted conventional therapeutic options. Together with partners, we work to change the legal framework, promote expanded access programs, educate health practitioners and support patients and their caregivers.
Partners
Follow us
We are committed to advance legal therapeutic use and scientific research of psychedelics in Ukraine
